|drug2395||PHQ-9 Depression Scale Wiki||1.00|
|drug44||38-questions questionnaire Wiki||1.00|
|D058186||Acute Kidney Injury NIH||0.22|
|D014947||Wounds and Injuries NIH||0.19|
There is one clinical trial.
The aim of this study is to assess the maternal psychological implication of the novel coronavirus COvid-19 pandemic. At the same time it will be evaluated whether there is an impact of these implications on the anaesthetic practice.
Description: Association between Covid-19 pandemic and maternal psychological distress assessed by 2 scales and one questionnaireMeasure: Association between Covid-19 pandemic and maternal psychological distress Time: Pre-labour assessment
Description: Association between Covid-19 pandemic and anaesthetic practice assessed by a 38 questions questionnaireMeasure: Association between Covid-19 pandemic, maternal psychological distress and anaesthetic practice Time: Pre-labour assessment
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.Drug Reports MeSH Reports HPO Reports